Objective Statins have been demonstrated to improve outcomes in patients receiving
immune checkpoint blockade (ICB). This study aimed to investigate whether the timing of …

e14672 Background: Concomitant use of statins has been associated with improved survival
outcomes in patients treated with immune checkpoint inhibitors (ICIs), but it is unclear if the …

Background: Statins are associated with improved survival outcomes in patients receiving
immune checkpoint inhibitors (ICIs), but the impact of lipophilic and hydrophilic statin …

Immunotherapy shows promising therapeutic efficacy against various types of cancer, but
most fail to respond. Preclinical studies have suggested that concomitant medications, such …

In the past decade, immune checkpoint inhibitor (ICI) therapy significantly improved the
prognosis of patients with cancer. Despite impressive and often unprecedented response …

Statins are suggested to improve cancer survival by possible anti‐inflammatory effect.
However, it remains unclear if concomitant use of statins could improve the efficacy of …

Background Anti-programmed cell death protein-1 (PD-1) immune checkpoint blockade
(ICB) has become a common first line treatment for head and neck squamous cell carcinoma …

Background: In advanced non-small cell lung cancer (NSCLC), immune checkpoint
inhibitors (ICIs) significantly improved patients (pts) prognosis, even if many factors could …

Immune checkpoint inhibitors (ICI) have improved survival in numerous types of cancer.
However, a great number of unselected patients still do not respond to ICI. Moreover, there …

Background Statins are commonly used agents in primary and secondary prevention of
cardiovascular disease, but recent studies suggested that they can display pleiotropic effects …